BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19524447)

  • 1. Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.
    Thomas PA
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):431-2. PubMed ID: 19524447
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L; Robinson LA; Wagner H
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management algorithms for stage IIIA non-small cell lung cancer with N2 node involvement.
    Detterbeck F; Sukumar MS
    Thorac Surg Clin; 2008 Nov; 18(4):437-41, vii. PubMed ID: 19086612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bronchial cancer--development, diagnosis, therapy, prognosis].
    Zöchbauer S; Krajnik G; Huber H
    Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the management of stage IIIA non-small-cell lung cancer.
    Santos ES; Castrellon A; Blaya M; Raez LE
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1913-29. PubMed ID: 19046112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined-modality treatment of non-small-cell lung cancer stages I-III (take home messages).
    Rübe C; Fleckenstein J
    Lung Cancer; 2004 Aug; 45 Suppl 2():S139-41. PubMed ID: 15552794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of unresectable stage III non-small-cell lung carcinomas].
    Van Houtte P
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S24-6. PubMed ID: 17404535
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
    Manegold C; Schirren J; Schneider P; Drings P; Vogt-Moykopf I; Schraube P; Wannenmacher M
    Pneumologie; 1996 Oct; 50(10):735-41. PubMed ID: 9019754
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-small cell lung cancer].
    Yoshimura A; Niitani H
    Ryoikibetsu Shokogun Shirizu; 1994; (4):100-3. PubMed ID: 8007089
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of stage III non-small lung carcinomas: is there controversy?].
    Mornex F; Girard N
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S20-3. PubMed ID: 17404534
    [No Abstract]   [Full Text] [Related]  

  • 13. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 14. Stage II (T3) lung cancer.
    Allen MS; Jett JR; Kozelsky TF
    Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
    Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer.
    D'Angelillo RM; Trodella L; Ramella S
    J Thorac Cardiovasc Surg; 2004 Sep; 128(3):489-90. PubMed ID: 15354115
    [No Abstract]   [Full Text] [Related]  

  • 17. [Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy].
    Fournel P
    Rev Pneumol Clin; 2004 Jun; 60 Spec no 2():2S8-15. PubMed ID: 15211226
    [No Abstract]   [Full Text] [Related]  

  • 18. Stage IIIB non-small-cell lung cancer.
    Rendina EA; Venuta F; De Giacomo T; Furio Coloni G
    Chest Surg Clin N Am; 2001 Feb; 11(1):101-19, viii. PubMed ID: 11253593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.